Literature DB >> 17098478

Coronary artery aneurysms in patients with hyper IgE recurrent infection syndrome.

Jennifer C Ling1, Alexandra F Freeman, Ahmed M Gharib, Andrew E Arai, Robert J Lederman, Douglas R Rosing, Steven M Holland.   

Abstract

Hyper IgE recurrent infection syndrome (HIES, or Job's syndrome) is a primary immunodeficiency characterized by recurrent skin and lung infections, eczema, elevated serum immunoglobulin E (IgE) levels, and various connective tissue and skeletal system abnormalities including characteristic facies, scoliosis, joint hyperextensibility, retained primary dentition, craniosynostosis, osteopenia, and pathologic fractures. We have identified two patients with aneurysmal coronary artery disease. One was a forty-three-year-old man with HIES and coronary artery aneurysms and ectasia identified on cardiac catheterization following myocardial infarction. The other was a 48-year-old man with coronary artery ectasia-aneurysm identified after cardiac catheterization for evaluation of chest pain. Although connective tissue abnormalities are common in HIES, this is the first report of coronary artery aneurysms in HIES. Further studies are necessary to determine the incidence, pathogenesis, and optimal therapy of these arterial abnormalities in HIES.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17098478      PMCID: PMC6588833          DOI: 10.1016/j.clim.2006.10.005

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  18 in total

Review 1.  Hyper-IgE syndrome update.

Authors:  Kathryn J Sowerwine; Steven M Holland; Alexandra F Freeman
Journal:  Ann N Y Acad Sci       Date:  2012-01-23       Impact factor: 5.691

2.  Paucity of genotype-phenotype correlations in STAT3 mutation positive Hyper IgE Syndrome (HIES).

Authors:  Jennifer Heimall; Joie Davis; Pamela A Shaw; Amy P Hsu; Wenjuan Gu; Pam Welch; Steven M Holland; Alexandra F Freeman
Journal:  Clin Immunol       Date:  2011-01-14       Impact factor: 3.969

Review 3.  Th17 cells, Job's syndrome and HIV: opportunities for bacterial and fungal infections.

Authors:  Joshua D Milner; Netanya G Sandler; Daniel C Douek
Journal:  Curr Opin HIV AIDS       Date:  2010-03       Impact factor: 4.283

4.  Successful haploidentical donor hematopoietic stem cell transplant and restoration of STAT3 function in an adolescent with autosomal dominant hyper-IgE syndrome.

Authors:  N C Patel; J L Gallagher; T R Torgerson; A L Gilman
Journal:  J Clin Immunol       Date:  2015-05-12       Impact factor: 8.317

5.  Coronary atherosclerosis and dilation in hyper IgE syndrome patients: Depiction by magnetic resonance vessel wall imaging and pathological correlation.

Authors:  Khaled Z Abd-Elmoniem; Nadine Ramos; Saami K Yazdani; Ahmed M Ghanem; Steven M Holland; Alexandra F Freeman; Ahmed M Gharib
Journal:  Atherosclerosis       Date:  2017-01-19       Impact factor: 5.162

6.  Hemoptysis in a Patient with Elevated Immunoglobulin E.

Authors:  Yael Gernez; Angela Tsuang; Tukisa D Smith; Khurram Shahjehan; Yiqun Hui; Paul J Maglione; Charlotte Cunningham-Rundles
Journal:  J Allergy Clin Immunol Pract       Date:  2016-09-29

7.  Coronary abnormalities in hyper-IgE recurrent infection syndrome: depiction at coronary MDCT angiography.

Authors:  Ahmed M Gharib; Roderic I Pettigrew; Abdalla Elagha; Amy Hsu; Pam Welch; Steven M Holland; Alexandra F Freeman
Journal:  AJR Am J Roentgenol       Date:  2009-12       Impact factor: 3.959

Review 8.  The hyper-IgE syndromes.

Authors:  Alexandra F Freeman; Steven M Holland
Journal:  Immunol Allergy Clin North Am       Date:  2008-05       Impact factor: 3.479

Review 9.  A review on the vascular features of the hyperimmunoglobulin E syndrome.

Authors:  H Yavuz; R Chee
Journal:  Clin Exp Immunol       Date:  2009-11-12       Impact factor: 4.330

10.  Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis.

Authors:  Soraya Taleb; Mélissa Romain; Bhama Ramkhelawon; Catherine Uyttenhove; Gerard Pasterkamp; Olivier Herbin; Bruno Esposito; Nicolas Perez; Hideo Yasukawa; Jacques Van Snick; Akihiko Yoshimura; Alain Tedgui; Ziad Mallat
Journal:  J Exp Med       Date:  2009-09-08       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.